Santhera Pharmaceuticals Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 21 shareholders own 54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
21.7%	Santhera Pharmaceuticals (Schweiz) AG	1,997,558	CHF19.0m	0%	no data
15.4%	Catalyst Pharmaceuticals, Inc.	1,414,688	CHF13.4m	0%	no data
14.1%	Idorsia Ltd	1,301,128	CHF12.4m	0%	no data
1.15%	Credit Suisse Asset Management (Switzerland) Ltd.	105,524	CHF1.0m	0%	no data
0.55%	ZKB Asset Management	50,454	CHF479.3k	0%	no data
0.21%	Pictet Asset Management Limited	19,367	CHF184.0k	0%	no data
0.19%	Zürcher Kantonalbank, Investment Arm	17,820	CHF169.3k	0%	no data
0.17%	JPMorgan Chase & Co, Brokerage and Securities Investments	16,126	CHF153.2k	-67%	no data
0.16%	BlackRock, Inc.	14,667	CHF139.3k	6.27%	no data
0.15%	Thomas Meier	14,032	CHF133.3k	0%	no data
0.12%	Patrick V. J. Vink	10,723	CHF101.9k	0%	no data
0.048%	Philipp Gutzwiller	4,446	CHF42.2k	0%	no data
0.033%	CATAM Asset Management AG	3,000	CHF28.5k	0%	0.03%
0.029%	Shabir Hasham	2,647	CHF25.2k	0%	no data
0.027%	Dario Eklund	2,500	CHF23.7k	0%	no data
0.011%	Günther Metz	1,000	CHF9.5k	0%	no data
0.0025%	Quorus Vermögensverwaltung AG	230	CHF2.2k	0%	no data
0.0018%	LLB Asset Management AG	165	CHF1.6k	0%	no data
0.0014%	Deka Investment GmbH	130	CHF1.2k	0%	no data
0.0013%	State Street Global Advisors, Inc.	121	CHF1.1k	0%	no data
0.00091%	Migrosbank Asset Management	84	CHF796.6	-56.7%	no data